| 发明名称 |
USE OF COMPOUNDS HAVING COMBINED DOPAMINE D2, 5-HT1A AND ALPHA ADRENORECEPTOR AGONISTIC ACTION FOR TREATING CNS DISORDERS |
| 摘要 |
The invention relates to the use of compounds having combined sopamine D2 agonistic activity, 5-HT1A agonistic activity and a adrenoceptor agonistic activity for the treatment of CNS disorders such as Parkinson's disease.</SD OAB>
|
| 申请公布号 |
CA2405758(A1) |
申请公布日期 |
2001.11.15 |
| 申请号 |
CA20012405758 |
申请日期 |
2001.05.10 |
| 申请人 |
SOLVAY PHARMACEUTICALS B.V. |
发明人 |
VAN DER HEIJDEN, JOHANNES A. M.;LONG, STEPHEN K.;FEENSTRA, ROELOF W.;VAN SCHARRENBURG, GUSTAAF J. M. |
| 分类号 |
C07D413/12;A61K31/00;A61K31/4184;A61K31/423;A61K31/428;A61K45/00;A61K45/06;A61P25/00;A61P25/14;A61P25/16;A61P25/28;A61P43/00;(IPC1-7):A61K31/428;A61K31/418 |
主分类号 |
C07D413/12 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
